Mária Kultanová, Juraj Kováčik
Marfan syndrome is a heritable systemic connective tissue disorder that affects many different organ systems of the patient,
mainly involving the skeletal, ocular and cardiovascular manifestations. Pathogenic change is the result of degeneration
of microfibril architecture and consequential loss of extracellular matrix integrity due to fibrillin-1 (gen FBN1)
mutations. Early identification and appropriate management is critical for patients with Marfan syndrome who are prone
to the lifethreatening complications. It is often difficult to confirm the diagnosis in infants, because many diagnostic
criteria can develop with age. Management of the patient with Marfan syndrome requires multidisciplinary approach.
This report want to assist in recognizing the features of Marfan syndrome and offer actual guidelines for pediatric
Marfan syndrome, including both conservative and surgical therapy modalities.